GTBPVSSOPH• 3 Months (Normalized)
GTBP vs SOPH (GT Biopharma Inc. vs SOPHiA GENETICS SA)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+1226.09%
GT Biopharma Inc.
Normalized Baseline0.00%
SOPH Performance $8.07
+48.35%
SOPHiA GENETICS SA
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1177.74 pts
GTBP outperforming by 1177.74 percentage points
GTBPSOPH
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP SOPH
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | GTBP Price | GTBP Gain (%) | SOPH Price | SOPH Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +1226.09% | $8.07 | +48.35% | +1177.74% |
| Sep 30, 2026 | $- | $8.38 | +54.04% | - | |
| Sep 29, 2026 | $6.88 | +1394.57% | $8.30 | +52.57% | +1342.00% |
| Sep 28, 2026 | $6.80 | +1378.26% | $8.49 | +56.07% | +1322.19% |
| Sep 25, 2026 | $6.89 | +1397.83% | $8.34 | +53.31% | +1344.52% |
| Sep 24, 2026 | $6.83 | +1384.78% | $8.26 | +51.84% | +1332.94% |
| Sep 23, 2026 | $7.10 | +1443.48% | $8.08 | +48.53% | +1394.95% |
| Sep 22, 2026 | $- | $8.07 | +48.35% | - | |
| Sep 21, 2026 | $7.18 | +1460.87% | $8.24 | +51.47% | +1409.40% |
| Sep 18, 2026 | $7.16 | +1456.52% | $8.19 | +50.55% | +1405.97% |
| Sep 17, 2026 | $7.49 | +1528.26% | $8.53 | +56.80% | +1471.46% |
| Sep 16, 2026 | $7.81 | +1597.83% | $7.98 | +46.60% | +1551.23% |
| Sep 15, 2026 | $9.00 | +1856.52% | $7.96 | +46.32% | +1810.20% |
| Sep 14, 2026 | $11.63 | +2428.26% | $7.86 | +44.49% | +2383.77% |
| Sep 11, 2026 | $8.61 | +1771.74% | $7.87 | +44.67% | +1727.07% |
Page 1 of 5